naproxen has been researched along with amoxicillin in 37 studies
Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (amoxicillin) | Trials (amoxicillin) | Recent Studies (post-2010) (amoxicillin) |
---|---|---|---|---|---|
4,551 | 1,057 | 1,429 | 10,915 | 2,661 | 3,467 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (2.70) | 18.7374 |
1990's | 4 (10.81) | 18.2507 |
2000's | 6 (16.22) | 29.6817 |
2010's | 24 (64.86) | 24.3611 |
2020's | 2 (5.41) | 2.80 |
Authors | Studies |
---|---|
Ax, F; Bonham, NM; Hallberg, A; Karlén, A; Lennernäs, H; Winiwarter, S | 1 |
Danelian, E; Hämäläinen, MD; Hansson, A; Karlén, A; Karlsson, R; Lennernäs, H; Löfâs, S; Winiwarter, S | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Avdeef, A; Tam, KY | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Bourgeois, V; Depierreux, M; Ducobu, J; Dupont, P; Nortier, J | 1 |
Bourgeois, V; Depierreux, M; Dupont, P; Nortier, J | 1 |
Grossman, JE; Varsano, IB; Volovitz, BM | 1 |
Lapière, CM; Nusgens, BV; Paquet, P; Piérard, GE | 1 |
Schretter-Irschick, E; Yayan, J | 1 |
Acero, JL; Benitez, FJ; Real, FJ; Roldan, G | 1 |
Domínguez-Pérez, Á; Iribarren-Marín, Mdel A; Martín-García, C; Pérez-Vega, H | 1 |
Acero, JL; Benitez, FJ; Casas, F; Real, FJ; Roldan, G | 1 |
Escribano, E; Navarro, CR; Regué, JQ; Sala, XG; Salamanca, J | 1 |
Feo-Brito, F; Herreros, B; Méndez, Y; Urra, JM | 1 |
Cristina, RH; María Jesús, MV; Miguel Ángel, BL; Rut, FT | 1 |
Bello-López, MÁ; López-Pérez, G; Martín-Valero, MJ; Román-Hidalgo, C | 1 |
Horikoshi, Y; Miura, M; Uda, K | 1 |
Chen, Y; Li, L; Zheng, S | 1 |
Hassib, ST; Mostafa, EA; Sharf, MG; Taha, EA | 1 |
Banerjee, A; Castelletto, V; Chatterjee, A; Das, S; Gachhui, R; Hamley, IW; Hansda, B; Kumar, S; Majumder, J; Mondal, B; Sen, P | 1 |
1 review(s) available for naproxen and amoxicillin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for naproxen and amoxicillin
Article | Year |
---|---|
Effect of naproxen, a prostaglandin inhibitor, on acute otitis media and persistence of middle ear effusion in children.
Topics: Acute Disease; Amoxicillin; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Naproxen; Otitis Media with Effusion; Prostaglandin Antagonists; Random Allocation | 1989 |
35 other study(ies) available for naproxen and amoxicillin
Article | Year |
---|---|
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.
Topics: Humans; Intestinal Absorption; Jejunum; Models, Biological; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship | 1998 |
SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans.
Topics: Humans; Intestinal Absorption; Liposomes; Pharmaceutical Preparations; Pharmacokinetics; Predictive Value of Tests; Surface Plasmon Resonance | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Progression of a naproxen and amoxicillin induced acute interstitial nephritis with nephrotic syndrome: case report.
Topics: Adult; Amoxicillin; Biopsy; Humans; Kidney; Kidney Failure, Chronic; Male; Naproxen; Nephritis, Interstitial; Nephrotic Syndrome; Pneumonia | 1991 |
Acute interstitial nephritis with nephrotic syndrome after intake of naproxen and amoxycillin.
Topics: Adult; Amoxicillin; Humans; Male; Naproxen; Nephritis, Interstitial; Nephrotic Syndrome | 1990 |
Gelatinases in drug-induced toxic epidermal necrolysis.
Topics: Adult; Aged; Amoxicillin; Biopsy; Blister; Child, Preschool; Collagenases; Enzyme Activation; Female; Gelatinases; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloendopeptidases; Middle Aged; Naproxen; Phenytoin; Piroxicam; Stevens-Johnson Syndrome | 1998 |
Localized episcleritis-like lesions on both eyes in a patient with para nasal sinusitis.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Drug Therapy, Combination; Humans; Magnetic Resonance Imaging; Maxillary Sinusitis; Naproxen; Scleritis | 2008 |
Kinetics of aqueous chlorination of some pharmaceuticals and their elimination from water matrices.
Topics: Amoxicillin; Fresh Water; Halogenation; Hydrogen-Ion Concentration; Kinetics; Metoprolol; Naproxen; Pharmaceutical Preparations; Phenacetin; Water Pollutants, Chemical; Water Purification | 2010 |
[Spondylodiscitis caused by Streptococcus pneumonia associated with an infected abdominal aortic aneurysm].
Topics: Alcoholism; Amoxicillin; Aneurysm, Infected; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aortic Aneurysm, Abdominal; Aortitis; Blood Vessel Prosthesis Implantation; Combined Modality Therapy; Discitis; Disease Susceptibility; Humans; Lumbar Vertebrae; Male; Middle Aged; Naproxen; Pneumococcal Infections; Psoas Abscess; Pulmonary Disease, Chronic Obstructive; Rifampin; Tomography, X-Ray Computed | 2011 |
Bromination of selected pharmaceuticals in water matrices.
Topics: Amoxicillin; Halogenation; Hydrochlorothiazide; Hydrogen-Ion Concentration; Kinetics; Metoprolol; Naproxen; Pharmaceutical Preparations; Phenacetin; Water Pollutants, Chemical | 2011 |
Single-pass intestinal perfusion to establish the intestinal permeability of model drugs in mouse.
Topics: Amoxicillin; Animals; Furosemide; Humans; Intestinal Absorption; Intestinal Mucosa; Male; Mice; Models, Animal; Naproxen; Perfusion; Permeability; Pharmaceutical Preparations; Piroxicam; Ranitidine; Rats | 2012 |
Usefulness of basophil activation test for the diagnosis of IgE mediated hypersensitivity to tetanus toxoid vaccine.
Topics: Aged, 80 and over; Allergens; Amoxicillin; Anaphylaxis; Basophils; Cell Degranulation; Cells, Cultured; Diagnosis, Differential; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Immunologic Tests; Male; Naproxen; Tetanus Toxoid; Wounds, Stab | 2018 |
Use of Polymer Inclusion Membranes (PIMs) as support for electromembrane extraction of non-steroidal anti-inflammatory drugs and highly polar acidic drugs.
Topics: Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Cellulose; Electrochemical Techniques; Hippurates; Ibuprofen; Ketoprofen; Membranes, Artificial; Naproxen; Niacin; ortho-Aminobenzoates; Quaternary Ammonium Compounds; Salicylic Acid | 2018 |
Chitosan tailor-made membranes as biopolymeric support for electromembrane extraction.
Topics: Amoxicillin; Biopolymers; Chitosan; Electrochemical Techniques; Hippurates; Humans; Ibuprofen; Ketoprofen; Naproxen; Niacin; ortho-Aminobenzoates; Salicylic Acid | 2019 |
Prolonged PR interval in a patient with acute rheumatic fever.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Atrioventricular Block; Child, Preschool; Electrocardiography; Humans; Male; Naproxen; Rheumatic Fever; Rheumatic Heart Disease; Treatment Outcome | 2019 |
Stevens-Johnson syndrome and acute vanishing bile duct syndrome after the use of amoxicillin and naproxen in a child.
Topics: Amoxicillin; Bile Ducts; Child; Humans; Liver; Male; Naproxen; Stevens-Johnson Syndrome; Syndrome | 2019 |
RP-HPLC-DAD Method Development and Validation for Simultaneous Determination of Lansoprazole, Tinidazole, Amoxicillin, and Naproxen in Their Raw Materials and Combined Dosage Form: DOE Approach for Optimization of the Proposed Method.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Naproxen; Omeprazole; Research Design; Tinidazole | 2022 |
Histidine-Containing Amphiphilic Peptide-Based Non-Cytotoxic Hydrogelator with Antibacterial Activity and Sustainable Drug Release.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Drug Liberation; Escherichia coli; Histidine; Hydrogels; Mice; Naproxen; Peptides; Staphylococcus aureus | 2023 |